KR920016404A - 신규의 2-(2,6-디클로로아닐리노)-페닐아세트산염 및 그 제조방법과 국소 적용되는 약학적 제제의 용도 - Google Patents
신규의 2-(2,6-디클로로아닐리노)-페닐아세트산염 및 그 제조방법과 국소 적용되는 약학적 제제의 용도 Download PDFInfo
- Publication number
- KR920016404A KR920016404A KR1019920000940A KR920000940A KR920016404A KR 920016404 A KR920016404 A KR 920016404A KR 1019920000940 A KR1019920000940 A KR 1019920000940A KR 920000940 A KR920000940 A KR 920000940A KR 920016404 A KR920016404 A KR 920016404A
- Authority
- KR
- South Korea
- Prior art keywords
- salt
- rubidium
- cesium
- dichloroanilino
- water
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title claims 3
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title claims 2
- 238000002360 preparation method Methods 0.000 title 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical group [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 claims 4
- 229910052701 rubidium Inorganic materials 0.000 claims 4
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000003960 organic solvent Substances 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000035699 permeability Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
- C07C229/58—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 다음 일반식(Ⅰ)의 2-(2,6-디클로아닐리드)-페닐아세트산 염.상기식중, Me는 루비듐 또는 세슘 원자이다.
- 제1항에 있어서, 일반식(Ⅰ)의 Me+가 루비듐 원자임을 특징으로 하는 염.
- 제1항에 있어서, 일반식(Ⅰ)의 Me+가 세슘 원자임을 특징으로 하는 염.
- 제1항 내지 3항에 있어서, 2-(2,6-디클로로아닐리노)-페닐아세트산 또는 그의 나트륨 염을 수용성 알코올 용액 또는 수용성 유기 이상계 용액중에서 적당한 루비듐 또는 세슘염과 반응시킴을 특징으로 하는 염의 제조방법.
- 제4항에 있어서, 사용된 루비듐 또는 세슘 염이 클로라이드, 브로마이드,설페이트 또는 카보네이트임을 특징으로하는 제조방법.
- 활성성분으로서, 제1항 내지 3항중 어느 한항의 염과 생리적으로 적용 가능한 국소적용에 적합한 유기용매를 함유하고, 기타 생리적으로 적용가능한 보조 물질을 함유함을 특징으로 하는 약학적 제제.
- 제6항에 있어서, 물과 혼합물로서, 국소 적용에 적합한 유기용매를 함유함을 특징으로 하는 약학적 제제.
- 제6항 또는 7항에 있어서, 침투성을 증가시키는 화합물을 또한 함유함을 특징으로 하는 약학적 제제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91101674A EP0498011B1 (de) | 1991-02-07 | 1991-02-07 | Neue Salze der 2-(2,6-Dichloranilino)-phenylessigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung für topisch anwendbare pharmazeutische Zubereitungen |
EP91101674.9 | 1991-02-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR920016404A true KR920016404A (ko) | 1992-09-24 |
KR100203459B1 KR100203459B1 (ko) | 1999-06-15 |
Family
ID=8206378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920000940A KR100203459B1 (ko) | 1991-02-07 | 1992-01-23 | 2-(2,6-디클로로아닐리노)-페닐아세트산염, 그 제조방법 및 약학적 제제 |
Country Status (17)
Country | Link |
---|---|
US (1) | US5254583A (ko) |
EP (1) | EP0498011B1 (ko) |
JP (1) | JP3188741B2 (ko) |
KR (1) | KR100203459B1 (ko) |
AT (1) | ATE121724T1 (ko) |
AU (1) | AU640299B2 (ko) |
CA (1) | CA2059783C (ko) |
DE (1) | DE59105323D1 (ko) |
DK (1) | DK0498011T3 (ko) |
ES (1) | ES2072462T3 (ko) |
GR (1) | GR3015937T3 (ko) |
HU (2) | HUT62853A (ko) |
IE (1) | IE67183B1 (ko) |
IL (1) | IL100637A (ko) |
NZ (1) | NZ241455A (ko) |
PT (1) | PT100098B (ko) |
ZA (1) | ZA92288B (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN104895A0 (en) * | 1995-02-10 | 1995-03-09 | Lai, John | Methods of and preparations for the treatment of ailments and disorders |
US20080038376A1 (en) * | 2003-08-28 | 2008-02-14 | Pharmaionx, Inc. | Anti-cancer composition and method for using the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558690A (en) * | 1965-04-08 | 1971-01-26 | Gelgy Chemical Corp | Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation |
CH655656B (ko) * | 1982-10-07 | 1986-05-15 | ||
JPH06104624B2 (ja) * | 1986-05-07 | 1994-12-21 | 太郎 小木曽 | 経皮吸収剤 |
CH666621A5 (de) * | 1986-06-27 | 1988-08-15 | Ciba Geigy Ag | Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung. |
EP0380712B1 (de) * | 1989-01-27 | 1995-01-04 | HEUMANN PHARMA GMBH & CO | Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten |
TW225536B (ko) * | 1990-08-23 | 1994-06-21 | Ciba Geigy Ag |
-
1991
- 1991-02-07 DK DK91101674.9T patent/DK0498011T3/da active
- 1991-02-07 DE DE59105323T patent/DE59105323D1/de not_active Expired - Fee Related
- 1991-02-07 ES ES91101674T patent/ES2072462T3/es not_active Expired - Lifetime
- 1991-02-07 AT AT91101674T patent/ATE121724T1/de not_active IP Right Cessation
- 1991-02-07 EP EP91101674A patent/EP0498011B1/de not_active Expired - Lifetime
-
1992
- 1992-01-12 IL IL10063792A patent/IL100637A/en not_active IP Right Cessation
- 1992-01-15 ZA ZA92288A patent/ZA92288B/xx unknown
- 1992-01-17 AU AU10275/92A patent/AU640299B2/en not_active Ceased
- 1992-01-21 CA CA002059783A patent/CA2059783C/en not_active Expired - Fee Related
- 1992-01-23 KR KR1019920000940A patent/KR100203459B1/ko not_active IP Right Cessation
- 1992-01-30 NZ NZ241455A patent/NZ241455A/xx unknown
- 1992-01-31 JP JP01685192A patent/JP3188741B2/ja not_active Expired - Fee Related
- 1992-02-05 US US07/831,477 patent/US5254583A/en not_active Expired - Fee Related
- 1992-02-05 IE IE920374A patent/IE67183B1/en not_active IP Right Cessation
- 1992-02-06 HU HU9200363A patent/HUT62853A/hu unknown
- 1992-02-06 PT PT100098A patent/PT100098B/pt not_active IP Right Cessation
-
1994
- 1994-10-17 HU HU94P/P00039P patent/HU210536A9/hu unknown
-
1995
- 1995-04-27 GR GR950400163T patent/GR3015937T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR100203459B1 (ko) | 1999-06-15 |
AU1027592A (en) | 1992-08-13 |
ZA92288B (en) | 1992-10-28 |
IL100637A (en) | 1996-11-14 |
HU210536A9 (en) | 1995-04-28 |
US5254583A (en) | 1993-10-19 |
NZ241455A (en) | 1993-02-25 |
DK0498011T3 (da) | 1995-07-03 |
HUT62853A (en) | 1993-06-28 |
EP0498011A1 (de) | 1992-08-12 |
CA2059783C (en) | 2003-03-25 |
AU640299B2 (en) | 1993-08-19 |
HU9200363D0 (en) | 1992-04-28 |
EP0498011B1 (de) | 1995-04-26 |
JPH04312561A (ja) | 1992-11-04 |
JP3188741B2 (ja) | 2001-07-16 |
GR3015937T3 (en) | 1995-07-31 |
CA2059783A1 (en) | 1992-08-08 |
IE920374A1 (en) | 1992-08-12 |
IL100637A0 (en) | 1992-09-06 |
IE67183B1 (en) | 1996-03-06 |
ES2072462T3 (es) | 1995-07-16 |
ATE121724T1 (de) | 1995-05-15 |
PT100098B (pt) | 1999-08-31 |
DE59105323D1 (de) | 1995-06-01 |
PT100098A (pt) | 1993-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR840005083A (ko) | 항고혈압제로서 유용한 아미노산유도체의 제조방법 | |
KR900700093A (ko) | 수용성 이부프로펜 제제 및 그 제조방법 | |
MD1587B2 (en) | Retinoid composition and utilization thereof as therapeutic remedy for topical cutaneous application | |
KR910014103A (ko) | 사람의 손톱 처리용 국소 제제 | |
FI940696A (fi) | Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö | |
KR910016674A (ko) | 신규한 레티노이드 | |
KR920016404A (ko) | 신규의 2-(2,6-디클로로아닐리노)-페닐아세트산염 및 그 제조방법과 국소 적용되는 약학적 제제의 용도 | |
DK387884A (da) | Benzoesyrederivater, fremgangsmaade til deres fremstilling og deres anvendelse som desinficerende laegemidler eller konserveringsmidler | |
DK0647129T3 (da) | Præparat til topisk anvendelse | |
KR830009011A (ko) | 신규 구아니디노시 클로헥산카복실산 유도체 및 그의 제법 | |
KR940018351A (ko) | 노나테트라에노산 유도체 | |
KR850003710A (ko) | n-프로판올 아민 에테르 유도체의 제조방법 | |
DK401683A (da) | Substituerede benzensulfonsyreestere, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
SE7903200L (sv) | Farmaceutiskt, serskilt diuretiskt verksamt preparat for parenteral administration | |
KR840006767A (ko) | 항진균성 겔 조성물 | |
GB1296133A (ko) | ||
KR880012518A (ko) | 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물 | |
KR840006810A (ko) | 세팔로스포린 에스테르의 제조방법 | |
KR840001178A (ko) | N-메틸-d-글루카민염의 제조 | |
KR850000405A (ko) | 항진균제의 제조방법 | |
KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 | |
JPS6463552A (en) | 4-biphenylylacetic acid ester-cyclodextrin inclusion compound | |
KR880009026A (ko) | 리파마이신 유도체 염 | |
KR900013959A (ko) | γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물 | |
KR830005094A (ko) | 2-(4-이소부틸페닐)-프로피온산 유도체의 제조 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20020319 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |